American Association for Cancer Research (AACR)

AACR Scientific Podcasts

Scientific podcasts from the AACR's conferences.
AACR Scientific Podcasts


In the American Association for Cancer Research (AACR) scientific podcasts, we provide interviews with cancer researchers about their latest work as well as recordings of AACR teleconferences.



Science & Medicine


SABCS15 Wedesday Press Conference

Dec 10, 2015 01:03:18

AACR Project Genie Announcement

Nov 7, 2015 51:04


The American Association for Cancer Research (AACR) announced the launch of an international initiative known as AACR Project Genomics, Evidence, Neoplasia, Information, Exchange (GENIE). The initial phase of the project, which is being conducted in partnership with seven global leaders in genomic sequencing for clinical utility, as well as two informatics partners, will aggregate project members’ clinical-grade sequencing data to improve patient treatment decisions and catalyze clinical and translational research.

The seven founding members of the consortium and phase 1 participants are:

The Center for Personalized Cancer Treatment, Utrecht, Netherlands; Dana-Farber Cancer Institute, Boston; Institut Gustave Roussy, Villejuif, France; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore; Memorial Sloan Kettering Cancer Center, New York; Princess Margaret Cancer Centre, Toronto; and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

The two informatics partners are:

Sage Bionetworks, Seattle; and cBioPortal, New York.

Targets15 - Nov. 6 Press Teleconference

Nov 7, 2015 45:19


On Friday, Nov. 6, a press conference was held featuring a preview of the meeting with the conference co-chairs: Levi A. Garraway, MD, PhD, Dana-Farber Cancer Institute, Boston (AACR); Lee J. Helman, MD, NCI, Bethesda, Maryland (NCI); and Jean-Charles Soria, MD, PhD, Institut Gustave Roussy, Villejuif, France (EORTC).

The press conference also highlighted the following research:

Loss of SMAD4 Gene in Certain Colorectal Cancers is Associated With Poor Prognosis; and Pediatric Low-grade Gliomas with CRAF Fusions May Require Differential and Combinatorial Targeted Therapies